@article{APM10326,
author = {Ronald Chow and Saurabh Ray and May Tsao and Natalie Pulenzas and Liying Zhang and Arjun Sahgal and David Cella and Hany Soliman and Cyril Danjoux and Carlo DeAngelis and Sherlyn Vuong and Rachel McDonald and Edward Chow},
title = {Quality of life with Brain Symptom and Impact Questionnaire in patients with brain metastases},
journal = {Annals of Palliative Medicine},
volume = {5},
number = {3},
year = {2016},
keywords = {},
abstract = {Background: To examine the baseline characteristics of patients who underwent different treatments for brain metastases.
Methods: Allocated into group A [whole brain radiation therapy (WBRT) alone], or group B [stereotactic radiosurgery (SRS) or neurosurgery with or without WBRT], brain metastases patients with assigned treatment completed the Brain Symptom and Impact Questionnaire (BASIQ). Items of BASIQ were arranged as a symptom score or function score.
Results: Lung, breast, melanoma and renal cancer were the most prevalent primary cancer site among the study population, with 91 (53%), 25 (15%), 17 (10%) and 15 (9%) patients, respectively. Baseline BASIQ results were obtained before patients were treated with WBRT, neurosurgery, or SRS. Seventy-six (44%) and 96 patients (56%) were grouped to A and B, respectively. Group A reported lower quality of life (QOL) in all function scores (P},
issn = {2224-5839}, url = {https://apm.amegroups.org/article/view/10326}
}